V Atella

Summary

Affiliation: University of Rome Tor Vergata
Country: Italy

Publications

  1. ncbi Pharmaceutical price controls and minimum efficacy regulation: evidence from the United States and Italy
    Vincenzo Atella
    University of Rome Tor Vergata, Rome 00133, Italy
    Health Serv Res 47:293-308. 2012
  2. ncbi Drug cost containment policies in Italy: are they really effective in the long-run? The case of minimum reference price
    V Atella
    SEFEMEQ CEIS Faculty of Economics, University of Roma II Tor Vergata, Via di Tor Vergata snc, 00133, Rome, Italy
    Health Policy 50:197-218. 2000
  3. ncbi Determinants of access to physician services in Italy: a latent class seemingly unrelated probit approach
    Vincenzo Atella
    Department of Economics, CEIS Tor Vergata and SEFEMEQ, University of Rome Tor Vergata, Rome, Italy
    Health Econ 13:657-68. 2004
  4. ncbi Affordability of medicines and patients' cost-reducing behaviour: empirical evidence based on SUR estimates from Italy and the UK
    Vincenzo Atella
    Centre of International Studies on Economic Growth CEIS Dipartimento di Studi Economico Finanziari e Metodi Quantitativi SEFEMEQ, Faculty of Economics, University of Rome Tor Vergata, Rome, Italy
    Appl Health Econ Health Policy 4:23-35. 2005
  5. ncbi Drug compliance, co-payment and health outcomes: evidence from a panel of Italian patients
    Vincenzo Atella
    Faculty of Economics, University of Rome Tor Vergata, Rome, Italy
    Health Econ 15:875-92. 2006
  6. ncbi Are primary care physicians, public and private sector specialists substitutes or complements? Evidence from a simultaneous equations model for count data
    Vincenzo Atella
    CEIS SEFEMEQ, University of Rome Tor Vergata, Rome, Italy
    J Health Econ 27:770-85. 2008
  7. ncbi Are employers discriminating with respect to weight? European Evidence using Quantile Regression
    Vincenzo Atella
    University of Rome Tor Vergata, CEIS Tor Vergata and CHILD, Italy
    Econ Hum Biol 6:305-29. 2008
  8. ncbi Bridging science and health policy in cardiovascular disease: focus on lipid management: A Report from a Session held during the 7th International Symposium on Multiple Risk Factors in Cardiovascular Diseases: Prevention and Intervention--Health Policy, i
    V Atella
    Department of Economics, University of Rome Tor Vergata, Rome, Italy
    Atheroscler Suppl 10:3-21. 2009
  9. ncbi Cost to the patient or cost to the healthcare system? Which one matters the most for GP prescribing decisions? A UK-Italy comparison
    Karen Hassell
    School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Manchester, United Kingdom
    Eur J Public Health 13:18-23. 2003

Detail Information

Publications9

  1. ncbi Pharmaceutical price controls and minimum efficacy regulation: evidence from the United States and Italy
    Vincenzo Atella
    University of Rome Tor Vergata, Rome 00133, Italy
    Health Serv Res 47:293-308. 2012
    ....
  2. ncbi Drug cost containment policies in Italy: are they really effective in the long-run? The case of minimum reference price
    V Atella
    SEFEMEQ CEIS Faculty of Economics, University of Roma II Tor Vergata, Via di Tor Vergata snc, 00133, Rome, Italy
    Health Policy 50:197-218. 2000
    ..Changes in the up-ward trends can be obtained only with joint intervention on both supply and demand side. At the same time, a cost containment policy that acts on prices can have serious implications in terms of welfare...
  3. ncbi Determinants of access to physician services in Italy: a latent class seemingly unrelated probit approach
    Vincenzo Atella
    Department of Economics, CEIS Tor Vergata and SEFEMEQ, University of Rome Tor Vergata, Rome, Italy
    Health Econ 13:657-68. 2004
    ..Richer individuals are less likely to seek care from GP's and more likely to seek care from specialists, and especially private specialists. Health status and societal vulnerability are the most important indicators of class membership...
  4. ncbi Affordability of medicines and patients' cost-reducing behaviour: empirical evidence based on SUR estimates from Italy and the UK
    Vincenzo Atella
    Centre of International Studies on Economic Growth CEIS Dipartimento di Studi Economico Finanziari e Metodi Quantitativi SEFEMEQ, Faculty of Economics, University of Rome Tor Vergata, Rome, Italy
    Appl Health Econ Health Policy 4:23-35. 2005
    ..Therefore, the aim of this article is to explore empirically how, and to what extent, costs incurred by patients influence their decision-making behaviour in accessing medicines...
  5. ncbi Drug compliance, co-payment and health outcomes: evidence from a panel of Italian patients
    Vincenzo Atella
    Faculty of Economics, University of Rome Tor Vergata, Rome, Italy
    Health Econ 15:875-92. 2006
    ..Our results show that drug co-payment has a strong effect on compliance, and that this effect is immediate...
  6. ncbi Are primary care physicians, public and private sector specialists substitutes or complements? Evidence from a simultaneous equations model for count data
    Vincenzo Atella
    CEIS SEFEMEQ, University of Rome Tor Vergata, Rome, Italy
    J Health Econ 27:770-85. 2008
    ..Once common unobserved heterogeneity is properly accounted for, general practitioners, public and private specialists are found to be substitute sources of medical care. In contrast, a naive model finds they are complements...
  7. ncbi Are employers discriminating with respect to weight? European Evidence using Quantile Regression
    Vincenzo Atella
    University of Rome Tor Vergata, CEIS Tor Vergata and CHILD, Italy
    Econ Hum Biol 6:305-29. 2008
    ....
  8. ncbi Bridging science and health policy in cardiovascular disease: focus on lipid management: A Report from a Session held during the 7th International Symposium on Multiple Risk Factors in Cardiovascular Diseases: Prevention and Intervention--Health Policy, i
    V Atella
    Department of Economics, University of Rome Tor Vergata, Rome, Italy
    Atheroscler Suppl 10:3-21. 2009
    ..Failure to bridge the gap between science and health policy, particularly in relation to lipid management, could result in missed opportunities to reverse the burgeoning epidemic of CVD in Europe...
  9. ncbi Cost to the patient or cost to the healthcare system? Which one matters the most for GP prescribing decisions? A UK-Italy comparison
    Karen Hassell
    School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Manchester, United Kingdom
    Eur J Public Health 13:18-23. 2003
    ..This paper describes how the charge system influences the prescribing decisions of Italian and UK physicians...